Agenda

30/11/2022

Selective PARP-1 and PARP-2 inhibition in combination with PD-1/PD-L1 axis blockade as a treatment strategy in Small Cell Lung Cancer / A ?-catenin-dependent RNA biogenesis program promotes TALL therapy resistance

Marie Curie room at 14:00h

Us convidem al pròxim IMIM Seminar organitzat pel programa de càncer que tindrà lloc el dimecres 30/11/2022 a les 14:00h. El seminari constarà de dues xerrades, una a càrrec de Miguel Galindo, investigador postdoctoral del grup de recerca en teràpia molecular del càncer (IMIM) amb el títol "Selective PARP-1 and PARP-2 inhibition in combination with
PD-1/PD-L1 axis blockade as a treatment strategy in Small Cell Lung Cancer" i l'altra a càrrec de Violeta García, PhD, investigadora postdoctoral del grup de recerca en Cèl·lules mare i càncer (IMIM) amb el títol "A β-catenin-dependent RNA biogenesis program promotes TALL therapy resistance".

________________________________________________________________

We invite you to the next IMIM Seminar organized by the cancer program that will take place on Wednesday 30 November 2022 at 14:00 h. The seminar will consist of two talks, one by Miguel Galindo, Molecular cancer therapeutics research group (IMIM), entitled "Selective PARP-1 and PARP-2 inhibition in combination with PD-1/PD-L1 axis blockade as a treatment strategy in Small Cell Lung Cancer" and the other by Violeta García, PhD, postdoctoral researcher. Stem cells and cancer research group (IMIM), which will be entitled: "A β-catenin-dependent RNA biogenesis program promotes TALL therapy resistance".

Pòster

Tots els actes